A Phenolic Antioxidant Releasing Nitric Oxide on Demand
Rayonet photochemical reactor equipped with 8 RPR lamps with
an emission in the 380–480 nm range with a maximum at 420 nm
in the presence of a 400 nm cut-off filter. The incident photon flux
on quartz cuvettes was ca. 1ϫ1015 quanta/sec.
novel classes of multitarget compounds for biomedical re-
search.
Laser Flash Photolysis: The samples were excited with the third
harmonic of a Nd-YAG Continuum Surelite II-10 laser system
(pulse width 6 ns FWHM, at λ = 355 nm) and the excited solutions
were analyzed at a right angle geometry by using a mini mLFP-111
apparatus developed by Luzchem Research. Briefly, the monitoring
beam was supplied by a ceramic xenon lamp and delivered through
quartz fiber optical cables. The laser pulse was probed by fiber that
synchronized the mLFP system with a Tektronix TDS 3032 digi-
tizer operating in the pretrigger mode. The signals from a compact
Hamamatsu photomultiplier were initially captured by the digitizer
and then transferred to a personal computer that controlled the
experiment with Luzchem software developed in the LabView 5.1
environment from National Instruments. The energy of the laser
pulse was measured at each laser shot by a SPHD25 Scientech py-
roelectric energy monitor. Oxygen was removed by vigorously bub-
bling the solutions with a constant flux of argon previously passed
through a water trap. The solution (in a flow cell of 1 cm path
length) was renewed after each laser shot. The sample temperature
was 295Ϯ2 K.
Experimental Section
Materials: All chemicals were purchased from Sigma–Aldrich and
used as received. Di-tert-butyl peroxide was purchased from Ald-
rich and was passed through alumina before use. All solvent used
(from Carlo Erba, Milan) were analytical grade. Model compound
2 was synthesized according to our previously reported pro-
cedure,[10f] whereas model compound 3 was purchased from
Sigma–Aldrich and used as received.
4-(2-{[4-Nitro-3-(trifluoromethyl)phenyl]amino}ethyl)benzene-1,2-
diol (1): Compound 1 was synthesized by a two-step synthesis re-
ported in the following. Syntheses were carried out under a low
intensity level of visible light.
N-[2-(3,4-Dimethoxyphenyl)ethyl]-4-nitro-3-(trifluoromethyl)aniline
(1a): 2-(3,4-Dimethoxyphenyl)ethanamine (500 mg, 2.76 mmol), 4-
chloro-1-nitro-2-(trifluoromethyl)benzene (622 mg, 2.76 mmol),
and sodium carbonate (230 mg, 2.76 mmol) were heated at reflux
in CH3CN (15 mL) under continuous stirring for 16 h. After cool-
ing down to ambient temperature the resulting suspension was fil-
tered. The organic solution was concentrated under reduced pres-
sure and purified by column chromatography (silica gel; CH2Cl2/
cyclohexane, 7:3) to give 1a (4.1 g, 76%). C17H17F3N2O4 (370.33):
calcd. C 55.13, H 4.63, N 7.56; found C 54.32, H 4.78, N 7.15. MS
(ESI): m/z (%) = 371.2 (100) [M + H]+. 1H NMR (500 MHz,
CDCl3): δ = 8.00 (d, J = 9.2 Hz, 1 H, ArH), 7.15 (d, J = 2.4 Hz, 1
H, ArH), 6.84 (d, J = 8.2 Hz, 1 H, ArH), 6.75 (dd, J = 8.2, 1.8 Hz,
NO Detection: NO release was measured with a World Precision
Instrument, ISO-NO meter, equipped with a data acquisition sys-
tem, and based on direct amperometric detection of NO with short
response time (Ͻ5 s) and sensitivity range 1 nM–20 µ. The analog
signal was digitalized with a four-channel recording system and
transferred to a PC. The sensor was accurately calibrated by mixing
standard solutions of NaNO2 with 0.1 H2SO4 and 0.1 KI ac-
cording to the Equation (5).
1
1 H, ArH), 6.71 (d, J = 1.8 Hz, 1 H, ArH), 6.64 (dd, = 9.2,
2.4 Hz, 1 H, ArH), 4.58 (br. s, 1 H, NH), 4.26 (t, J = 7.2 Hz, 2 H,
NHCH2), 3.88 (s, 6 H, OCH3), 2.91 (t, J = 7.2 Hz, 2 H, ArCH2)
ppm.
–
4H+ + 2I– + 2NO2 Ǟ 2H2O + 2NO + I2
(5)
NO photorelease experiments were performed in a thermostatted
quartz cell (1 cm path length, 3 mL capacity) by using the mono-
chromatic radiation of 420 nm of a fluorimeter Fluorolog-2 (mod.
F-111) as the light source. NO measurements were carried out with
the electrode positioned outside the light path in order to avoid
false NO signal due to photoelectric interference on the ISO-NO
electrode.
4-(2-{[4-Nitro-3-(trifluoromethyl)phenyl]amino}ethyl)benzene-1,2-
diol (1): Compound 1a (120 mg, 0.32 mmol) was dissolved in anhy-
drous CH2Cl2 (12 mL) and cooled to –78 °C. Afterwards, BBr3 (1
in CH2Cl2, 2.1 mL) was added dropwise. The reaction mixture was
stirred for 2 h at this temperature and then overnight (16 h) at room
temperature. Upon completion, the reaction mixture was quenched
by adding water and extracted with CH2Cl2. The organic layer was
washed with water, dried with anhydrous Na2SO4 and concen-
trated. The residue was purified by flash column chromatography
(2–6% MeOH in CH2Cl2) to afford desired product 1 (80 mg,
73%). C15H13F3N2O4 (342.27): calcd. C 52.64, H 3.83, N 8.18;
found C 52.12, H 3.95, N 7.95. MS (ESI): m/z (%) = 343.3 (100)
Acknowledgments
We thank the Università di Catania (Progetti di Ateneo) for finan-
cial support.
1
[M + H]+. H NMR (500 MHz, CDCl3): δ = 7.71 (d, J = 9.2 Hz,
1 H, ArH), 7.53 (d, J = 2.4 Hz, 1 H, ArH), 6.98 (d, J = 1.9 Hz, 1
H, ArH), 6.85 (d, J = 7.8 Hz, 1 H, ArH), 6.83 (dd, J = 7.8, 1.9 Hz,
1 H, ArH), 6.64 (dd, J = 9.2, 2.4 Hz, 1 H, ArH), 5.83 (br. s, 1 H,
NH), 4.21 (t, J = 7.2 Hz, 2 H, NHCH2), 2.98 (t, J = 7.2 Hz, 2 H,
ArCH2) ppm.
[1] a) R. Morphy, Z. Rankovic, J. Med. Chem. 2005, 48, 6523–
6543 and references cited therein; b) J. A. Christiaans, H.
Timmerman, Eur. J. Pharm. Sci. 1996, 4, 1–22.
[2] B. L. Roth, D. J. Sheffler, W. K. Kroeze, Nat. Rev. Drug Discov-
ery 2004, 3, 353–359.
Instrumentation: 1H NMR spectra were recorded with a Varian IN-
OVA 200 spectrometer, using TMS as internal standard. Mass spec-
tra were recorded with an Agilent 1100 series ESI/MSD spectrome-
ter. Experimental conditions were as follows: capillary voltage,
3.5 KV; fragmentor, 100 V; source temperature, 350 °C; drying gas,
N2 (10 L/min), carrier solvent, methanol (0.4 mL/min). The sam-
ples were dissolved in methanol containing trifluoroacetic acid.
UV/Vis absorption spectra were recorded with a Jasco V-560 spec-
trophotometer. Photolysis experiments were carried out in a ther-
mostatted quartz cell (1 cm path length, 3 mL capacity) by using a
[3] C. T. Keith, A. A. Borisy, B. R. Stockwell, Nat. Rev. Drug Dis-
covery 2005, 4, 1–78.
[4] A. Gasco, D. Boschi, K. Chegaev, C. Cena, A. Di Stilo, R.
Fruttero, L. Lazzarato, B. Rolando, P. Tosco, Pure Appl. Chem.
2008, 80, 1693–1701.
[5] a) L. J. Ignarro, Nitric Oxide Biology and Pathobiology, 1st ed.
Academic Press, San Diego, CA, 2000, p. 41; b) E. Culotta,
D. E. Koshland, Science 1992, 258, 1862–1865; c) L. J. Ignarro,
Angew. Chem. Int. Ed. 1999, 38, 1882–1892; d) F. Murad, An-
gew. Chem. Int. Ed. 1999, 38, 1856–1868; e) R. F. Furchgott,
Angew. Chem. Int. Ed. 1999, 38, 1870–1880.
Eur. J. Org. Chem. 2010, 421–426
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
425